Bionano Genomics, Inc. (BNGO)

Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	18.35	5.49	24.57	38.45	17.31
Short-Term Investments	83.94	108.1	226.04	0	0
Cash & Cash Equivalents	102.29	113.59	250.61	38.45	17.31
Cash Growth	-9.95%	-54.68%	551.80%	122.10%	4.77%
Receivables	9.32	7.02	4.93	2.78	6.33
Inventory	22.89	29.76	12.39	3.32	3.44
Other Current Assets	5.62	6.93	4.48	2.25	1.17
Total Current Assets	140.12	157.3	272.41	46.79	28.26
Property, Plant & Equipment	32.48	28.96	20.94	4.91	1.95
Goodwill and Intangibles	33.97	118.43	83	8.65	0
Other Long-Term Assets	7.83	2.81	0.75	0.1	0
Total Long-Term Assets	74.29	150.2	104.69	13.66	1.95
Total Assets	214.4	307.5	377.1	60.45	30.21
Accounts Payable	10.38	12.53	10.77	2.93	2.7
Deferred Revenue	0.94	1	0.83	0.51	0.54
Current Debt	72.24	2.55	1.77	0	20.08
Other Current Liabilities	16.47	19.81	8.48	5.5	3.04
Total Current Liabilities	100.03	35.88	21.84	8.95	26.37
Long-Term Debt	7.18	9.12	8.93	16.33	0
Other Long-Term Liabilities	11.04	13.1	9.21	0.1	0.23
Total Long-Term Liabilities	18.22	22.22	18.14	16.42	0.23
Total Liabilities	118.25	58.1	39.98	25.37	26.59
Total Debt	79.41	11.67	10.7	16.33	20.08
Debt Growth	580.61%	9.09%	-34.48%	-18.72%	122.44%
Retained Earnings	-581.21	-348.72	-216.12	-143.68	-102.58
Comprehensive Income	0.02	-1.12	-0.54	0	0
Shareholders' Equity	96.16	249.4	337.12	35.08	3.61
Net Cash / Debt	22.88	101.92	239.92	22.12	-2.77
Net Cash / Debt Growth	-77.56%	-57.52%	984.42%	-	-
Net Cash Per Share	0.67	3.52	8.67	2.12	-1.85
Working Capital	40.09	121.41	250.57	37.84	1.89
Book Value Per Share	2.82	8.62	12.18	3.37	2.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).